Bruker PCI technology advancing the fight against infectious diseases

Infectious diseases and viruses are rarely far from the headlines, particularly now as researchers and scientists across the world race to find a vaccine for SARS-CoV-2. But getting such a product from the laboratory to the patient can be a lengthy and expensive process for it must first pass numerous and rigorous clinical tests. Early, or preclinical, tests forming the initial steps of the development process generate essential data regarding toxicity and feasibility. One particularly helpful tool aiding researchers at this early development stage is preclinical imaging (PCI). Bruker PCI systems, such as magnetic resonance imaging (MRI), positron emission tomography (PET), and computed tomography (CT), are used in most academic and pharmaceutical institutions employing small animal disease models. Using these imaging technologies, researchers can visualize living animals at organ level down to molecular level. Crucially, they enable researchers to observe how the animals respond to physiological or environmental changes.

Do you want to learn more? Read the whole article!